Brian D. Evavold - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Immunology, Molecular Biology, Cell Biology

104 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhao X, Kolawole EM, Chan W, Feng Y, Yang X, Gee MH, Jude KM, Sibener LV, Fordyce PM, Germain RN, Evavold BD, Garcia KC. Tuning T cell receptor sensitivity through catch bond engineering. Science (New York, N.Y.). 376: eabl5282. PMID 35389803 DOI: 10.1126/science.abl5282  0.46
2022 Ma VP, Hu Y, Kellner AV, Brockman JM, Velusamy A, Blanchard AT, Evavold BD, Alon R, Salaita K. The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation. Science Advances. 8: eabg4485. PMID 35213231 DOI: 10.1126/sciadv.abg4485  0.556
2021 Liu B, Kolawole EM, Evavold BD. Mechanobiology of T Cell Activation: To Catch a Bond. Annual Review of Cell and Developmental Biology. PMID 34213954 DOI: 10.1146/annurev-cellbio-120219-055100  0.566
2021 Zareie P, Szeto C, Farenc C, Gunasinghe SD, Kolawole EM, Nguyen A, Blyth C, Sng XYX, Li J, Jones CM, Fulcher AJ, Jacobs JR, Wei Q, Wojciech L, Petersen J, ... ... Evavold BD, et al. Canonical T cell receptor docking on peptide-MHC is essential for T cell signaling. Science (New York, N.Y.). 372. PMID 34083463 DOI: 10.1126/science.abe9124  0.607
2021 Dileepan T, Malhotra D, Kotov DI, Kolawole EM, Krueger PD, Evavold BD, Jenkins MK. MHC class II tetramers engineered for enhanced binding to CD4 improve detection of antigen-specific T cells. Nature Biotechnology. PMID 33941928 DOI: 10.1038/s41587-021-00893-9  0.617
2021 Kim H, Perovanovic J, Shakya A, Shen Z, German CN, Ibarra A, Jafek JL, Lin NP, Evavold BD, Chou DH, Jensen PE, He X, Tantin D. Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes. The Journal of Experimental Medicine. 218. PMID 33295943 DOI: 10.1084/jem.20200533  0.413
2020 Kolawole EM, Lamb TJ, Evavold BD. Relationship of 2D Affinity to T Cell Functional Outcomes. International Journal of Molecular Sciences. 21. PMID 33120989 DOI: 10.3390/ijms21217969  0.583
2020 Singh NK, Alonso JA, Harris DT, Anderson SD, Ma J, Hellman LM, Rosenberg AM, Kolawole EM, Evavold BD, Kranz DM, Baker BM. An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes. Biochemistry. PMID 33074657 DOI: 10.1021/acs.biochem.0c00689  0.497
2020 Ren HM, Kolawole EM, Ren M, Jin G, Netherby-Winslow CS, Wade Q, Shwetank, Rahman ZSM, Evavold BD, Lukacher AE. IL-21 from high-affinity CD4 T cells drives differentiation of brain-resident CD8 T cells during persistent viral infection. Science Immunology. 5. PMID 32948671 DOI: 10.1126/Sciimmunol.Abb5590  0.62
2020 Krummey SM, Morris AB, Jacobs JR, McGuire DJ, Ando S, Tong KP, Zhang W, Robertson J, Guasch SA, Araki K, Larsen CP, Evavold BD, Kissick HT, Ford ML. CD45RB Status of CD8 T Cell Memory Defines T Cell Receptor Affinity and Persistence. Cell Reports. 30: 1282-1291.e5. PMID 32023448 DOI: 10.1016/J.Celrep.2020.01.016  0.716
2019 Bettini M, Scavuzzo MA, Liu B, Kolawole E, Guo L, Evavold BD, Borowiak M, Bettini ML. A Critical Insulin TCR Contact Residue Selects High Affinity and Pathogenic Insulin Specific T Cells. Diabetes. PMID 31836691 DOI: 10.2337/Db19-0821  0.541
2019 Liu B, Hood JD, Kolawole EM, Woodruff DM, Vignali DA, Bettini M, Evavold BD. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery. Diabetes. PMID 31806623 DOI: 10.2337/Db19-0399  0.609
2019 Spear TT, Evavold BD, Baker BM, Nishimura MI. Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 31595324 DOI: 10.1007/S00262-019-02401-0  0.602
2019 Chow IT, Gates TJ, Papadopoulos GK, Moustakas AK, Kolawole EM, Notturno RJ, McGinty JW, Torres-Chinn N, James EA, Greenbaum C, Nepom GT, Evavold BD, Kwok WW. Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer-mediated autoimmune diabetes. Science Advances. 5: eaaw9336. PMID 31457096 DOI: 10.1126/Sciadv.Aaw9336  0.575
2019 Shwetank, Frost EL, Mockus TE, Ren HM, Toprak M, Lauver MD, Netherby-Winslow CS, Jin G, Cosby JM, Evavold BD, Lukacher AE. PD-1 Dynamically Regulates Inflammation and Development of Brain-Resident Memory CD8 T Cells During Persistent Viral Encephalitis. Frontiers in Immunology. 10: 783. PMID 31105690 DOI: 10.3389/Fimmu.2019.00783  0.42
2019 Wu P, Zhang T, Liu B, Fei P, Cui L, Qin R, Zhu H, Yao D, Martinez RJ, Hu W, An C, Zhang Y, Liu J, Shi J, Fan J, ... ... Evavold BD, et al. Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition. Molecular Cell. PMID 30711376 DOI: 10.1016/J.Molcel.2018.12.018  0.484
2018 Hong J, Ge C, Jothikumar P, Yuan Z, Liu B, Bai K, Li K, Rittase W, Shinzawa M, Zhang Y, Palin A, Love P, Yu X, Salaita K, Evavold BD, et al. A TCR mechanotransduction signaling loop induces negative selection in the thymus. Nature Immunology. PMID 30420628 DOI: 10.1038/S41590-018-0259-Z  0.5
2018 Kolawole EM, Andargachew R, Liu B, Jacobs JR, Evavold BD. 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes. Frontiers in Immunology. 9: 2348. PMID 30374353 DOI: 10.3389/Fimmu.2018.02348  0.525
2018 DiToro D, Winstead CJ, Pham D, Witte S, Andargachew R, Singer JR, Wilson CG, Zindl CL, Luther RJ, Silberger DJ, Weaver BT, Kolawole EM, Martinez RJ, Turner H, Hatton RD, ... ... Evavold BD, et al. Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells. Science (New York, N.Y.). 361. PMID 30213884 DOI: 10.1126/Science.Aao2933  0.571
2018 Sibener LV, Fernandes RA, Kolawole EM, Carbone CB, Liu F, McAffee D, Birnbaum ME, Yang X, Su LF, Yu W, Dong S, Gee MH, Jude KM, Davis MM, Groves JT, ... ... Evavold BD, et al. Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding. Cell. 174: 672-687.e27. PMID 30053426 DOI: 10.1016/J.Cell.2018.06.017  0.548
2018 Sanecka A, Yoshida N, Kolawole EM, Patel H, Evavold BD, Frickel EM. T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103 Memory Status of CD8 T Cells in the Brain. Frontiers in Immunology. 9: 1290. PMID 29922298 DOI: 10.3389/Fimmu.2018.01290  0.666
2018 Andargachew R, Martinez RJ, Kolawole EM, Evavold BD. CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 29777029 DOI: 10.4049/Jimmunol.1800295  0.518
2017 Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, ... ... Evavold BD, et al. Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Cancer Immunology, Immunotherapy : Cii. PMID 29264697 DOI: 10.1007/S00262-017-2102-Z  0.441
2017 Cole DK, Fuller A, Dolton G, Zervoudi E, Legut M, Miles K, Blanchfield L, Madura F, Holland CJ, Bulek AM, Bridgeman JS, Miles JJ, Schauenburg AJA, Beck K, Evavold BD, et al. Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope. Frontiers in Immunology. 8: 1503. PMID 29209312 DOI: 10.3389/Fimmu.2017.01503  0.38
2017 Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, ... ... Evavold BD, et al. Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Cancer Immunology, Immunotherapy : Cii. PMID 29052782 DOI: 10.1007/S00262-017-2073-0  0.578
2017 Blanchfield L, Sabatino JJ, Lawrence L, Evavold BD. NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 28887429 DOI: 10.4049/Jimmunol.1700792  0.843
2016 Martinez RJ, Andargachew R, Martinez HA, Evavold BD. Low-affinity CD4+ T cells are major responders in the primary immune response. Nature Communications. 7: 13848. PMID 27976744 DOI: 10.1038/Ncomms13848  0.7
2016 Baker BM, Evavold BD. MHC Bias by T Cell Receptors: Genetic Evidence for MHC and TCR Coevolution. Trends in Immunology. PMID 27939452 DOI: 10.1016/J.It.2016.11.003  0.585
2016 Bally AP, Tang Y, Lee JT, Barwick BG, Martinez R, Evavold BD, Boss JM. Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory. Journal of Immunology (Baltimore, Md. : 1950). PMID 27895178 DOI: 10.4049/Jimmunol.1601464  0.523
2016 Pennati A, Ng S, Wu Y, Murphy JR, Deng J, Rangaraju S, Asress S, Blanchfield JL, Evavold B, Galipeau J. Regulatory B cells induce formation of IL-10 expressing T cells in mice with autoimmune neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27821578 DOI: 10.1523/Jneurosci.1994-16.2016  0.61
2016 Martinez RJ, Morris AB, Neeld DK, Evavold BD. Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection. European Journal of Immunology. PMID 27354309 DOI: 10.1002/Eji.201646475  0.532
2016 Ma VP, Liu Y, Blanchfield L, Su H, Evavold BD, Salaita K. Ratiometric tension probes for mapping receptor forces and clustering at intermembrane junctions. Nano Letters. PMID 27192323 DOI: 10.1021/Acs.Nanolett.6B01817  0.384
2016 Liu Y, Blanchfield L, Ma VP, Andargachew R, Galior K, Liu Z, Evavold B, Salaita K. DNA-based nanoparticle tension sensors reveal that T-cell receptors transmit defined pN forces to their antigens for enhanced fidelity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27140637 DOI: 10.1073/Pnas.1600163113  0.635
2016 Shorter SK, Schnell FJ, McMaster SR, Pinelli DF, Andargachew R, Evavold BD. Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses. Plos One. 11: e0149582. PMID 26915099 DOI: 10.1371/Journal.Pone.0149582  0.692
2016 Krummey SM, Martinez RJ, Andargachew R, Liu D, Wagener M, Kohlmeier JE, Evavold BD, Larsen CP, Ford ML. Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 26864034 DOI: 10.4049/Jimmunol.1500639  0.748
2016 Merkenschlager J, Ploquin MJ, Eksmond U, Andargachew R, Thorborn G, Filby A, Pepper M, Evavold B, Kassiotis G. Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response. Nature Communications. 7: 10281. PMID 26728651 DOI: 10.1038/Ncomms10281  0.665
2016 Merkenschlager J, Ploquin MJ, Eksmond U, Andargachew R, Thorborn G, Filby A, Pepper M, Evavold B, Kassiotis G. Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response Nature Communications. 7. DOI: 10.1038/ncomms10281  0.509
2015 Martinez RJ, Evavold BD. Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response. Frontiers in Immunology. 6: 468. PMID 26441973 DOI: 10.3389/Fimmu.2015.00468  0.66
2015 Hood JD, Zarnitsyna VI, Zhu C, Evavold BD. Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 26385521 DOI: 10.4049/Jimmunol.1501464  0.615
2015 Frost EL, Kersh AE, Evavold BD, Lukacher AE. Cutting Edge: Resident Memory CD8 T Cells Express High-Affinity TCRs. Journal of Immunology (Baltimore, Md. : 1950). 195: 3520-4. PMID 26371252 DOI: 10.4049/Jimmunol.1501521  0.567
2015 Hong J, Persaud SP, Horvath S, Allen PM, Evavold BD, Zhu C. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 3557-64. PMID 26336148 DOI: 10.4049/Jimmunol.1501407  0.621
2015 Martinez RJ, Neeld DK, Evavold BD. Identification of T cell clones without the need for sequencing. Journal of Immunological Methods. 424: 28-31. PMID 25960175 DOI: 10.1016/J.Jim.2015.04.018  0.541
2014 Kersh AE, Edwards LJ, Evavold BD. Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread. Journal of Immunology (Baltimore, Md. : 1950). 193: 4429-38. PMID 25267971 DOI: 10.4049/Jimmunol.1401456  0.564
2014 Bettini M, Blanchfield L, Castellaw A, Zhang Q, Nakayama M, Smeltzer MP, Zhang H, Hogquist KA, Evavold BD, Vignali DA. TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential. Journal of Immunology (Baltimore, Md. : 1950). 193: 571-9. PMID 24943217 DOI: 10.4049/Jimmunol.1400043  0.633
2014 Pryshchep S, Zarnitsyna VI, Hong J, Evavold BD, Zhu C. Accumulation of serial forces on TCR and CD8 frequently applied by agonist antigenic peptides embedded in MHC molecules triggers calcium in T cells. Journal of Immunology (Baltimore, Md. : 1950). 193: 68-76. PMID 24890718 DOI: 10.4049/Jimmunol.1303436  0.56
2014 Liu B, Chen W, Evavold BD, Zhu C. Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling. Cell. 157: 357-68. PMID 24725404 DOI: 10.1016/J.Cell.2014.02.053  0.399
2014 Krummey S, Martinez R, Liu D, Wagener M, Kohlmeier J, Evavold B, Larsen C, Ford M. Low Affinity CD8+ CD45RBhigh TNF-Producing TCM Are Potently Alloreactive Against High Affinity Antigen in a Model of T Cell Receptor Cross-Reactive Heterologous Immunity. Transplantation. 98: 33. DOI: 10.1097/00007890-201407151-00105  0.742
2014 Blanchfield L, Evavold B. CD4 + T affinity and cross-reactivity between MOG and NFM during the polyclonal response of MOG induced demyelinating autoimmune disease Journal of Neuroimmunology. 275: 196-197. DOI: 10.1016/J.Jneuroim.2014.08.528  0.56
2014 Liu B, Chen W, Evavold BD, Zhu C. Antigen-Specific TCR-Pmhc Catch Triggers T-Cell Signaling by Rapidly Accumulating Successive Bond Lifetimes Prolonged by Optimal Force Biophysical Journal. 106: 234a. DOI: 10.1016/J.Bpj.2013.11.1373  0.573
2013 Zarnitsyna VI, Evavold BD, Schoettle LN, Blattman JN, Antia R. Estimating the diversity, completeness, and cross-reactivity of the T cell repertoire. Frontiers in Immunology. 4: 485. PMID 24421780 DOI: 10.3389/Fimmu.2013.00485  0.58
2013 Edwards LJ, Evavold BD. Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells. Journal of Autoimmunity. 44: 82-90. PMID 23895744 DOI: 10.1016/J.Jaut.2013.07.002  0.641
2013 Blanchfield JL, Shorter SK, Evavold BD. Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology. Frontiers in Immunology. 4: 170. PMID 23840195 DOI: 10.3389/Fimmu.2013.00170  0.633
2013 Hofstetter AR, Evavold BD, Lukacher AE. Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice. Viral Immunology. 26: 109-13. PMID 23374150 DOI: 10.1089/Vim.2012.0052  0.588
2013 Zhu C, Jiang N, Huang J, Zarnitsyna VI, Evavold BD. Insights from in situ analysis of TCR-pMHC recognition: response of an interaction network. Immunological Reviews. 251: 49-64. PMID 23278740 DOI: 10.1111/Imr.12016  0.606
2012 Salinas GF, Krausz S, Dontje W, Evavold BD, Tak PP, Baeten DL, Reedquist KA. Sustained Rap1 activation in autoantigen-specific T lymphocytes attenuates experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 250: 35-43. PMID 22688423 DOI: 10.1016/J.Jneuroim.2012.05.012  0.572
2012 Edwards LJ, Zarnitsyna VI, Hood JD, Evavold BD, Zhu C. Insights into T cell recognition of antigen: significance of two-dimensional kinetic parameters. Frontiers in Immunology. 3: 86. PMID 22566966 DOI: 10.3389/Fimmu.2012.00086  0.581
2012 Rosenthal KM, Edwards LJ, Sabatino JJ, Hood JD, Wasserman HA, Zhu C, Evavold BD. Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics Plos One. 7. PMID 22412888 DOI: 10.1371/Journal.Pone.0032562  0.841
2012 Schubert DA, Gordo S, Sabatino JJ, Vardhana S, Gagnon E, Sethi DK, Seth NP, Choudhuri K, Reijonen H, Nepom GT, Evavold BD, Dustin ML, Wucherpfennig KW. Self-reactive human CD4 T cell clones form unusual immunological synapses. The Journal of Experimental Medicine. 209: 335-52. PMID 22312112 DOI: 10.1084/Jem.20111485  0.827
2012 Zinzow-Kramer WM, Long AB, Youngblood BA, Rosenthal KM, Butler R, Mohammed AU, Skountzou I, Ahmed R, Evavold BD, Boss JM. CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments. Genes and Immunity. 13: 299-310. PMID 22218223 DOI: 10.1038/Gene.2011.86  0.797
2011 Edwards LJ, Evavold BD. T cell recognition of weak ligands: roles of signaling, receptor number, and affinity. Immunologic Research. 50: 39-48. PMID 21365321 DOI: 10.1007/S12026-011-8204-3  0.641
2011 Jiang N, Huang J, Edwards LJ, Liu B, Zhang Y, Beal CD, Evavold BD, Zhu C. Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination. Immunity. 34: 13-23. PMID 21256056 DOI: 10.1016/J.Immuni.2010.12.017  0.82
2011 Sabatino JJ, Huang J, Zhu C, Evavold BD. High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. The Journal of Experimental Medicine. 208: 81-90. PMID 21220453 DOI: 10.1084/Jem.20101574  0.86
2011 Evavold BD, Allen PM. Pillars article: separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991. 252: 1308-1310 Journal of Immunology (Baltimore, Md. : 1950). 186: 9-12. PMID 21172873  0.379
2010 Huang J, Zarnitsyna VI, Liu B, Edwards LJ, Jiang N, Evavold BD, Zhu C. The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature. 464: 932-6. PMID 20357766 DOI: 10.1038/Nature08944  0.597
2010 Edwards LJ, Evavold BD. A unique unresponsive CD4+ T cell phenotype post TCR antagonism. Cellular Immunology. 261: 64-8. PMID 20031121 DOI: 10.1016/J.Cellimm.2009.11.002  0.661
2010 Sabatino JJ, Rosenthal KM, Evavold BD. Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 5: 176-88. PMID 19904613 DOI: 10.1007/S11481-009-9181-3  0.832
2009 Bettini M, Rosenthal K, Evavold BD. Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE. Journal of Neuroimmunology. 213: 60-8. PMID 19540601 DOI: 10.1016/J.Jneuroim.2009.05.017  0.848
2009 Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, Kasturi SP, Rosenthal KM, Evavold BD, Pulendran B. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nature Medicine. 15: 401-9. PMID 19252500 DOI: 10.1038/Nm.1925  0.827
2009 Schnell FJ, Alberts-Grill N, Evavold BD. CD8+ T cell responses to a viral escape mutant epitope: active suppression via altered SHP-1 activity. Journal of Immunology (Baltimore, Md. : 1950). 182: 1829-35. PMID 19201834 DOI: 10.4049/Jimmunol.0801798  0.539
2008 Wasserman HA, Beal CD, Zhang Y, Jiang N, Zhu C, Evavold BD. MHC variant peptide-mediated anergy of encephalitogenic T cells requires SHP-1. Journal of Immunology (Baltimore, Md. : 1950). 181: 6843-9. PMID 18981103 DOI: 10.4049/Jimmunol.181.10.6843  0.833
2008 Jones DS, Reichardt P, Ford ML, Edwards LJ, Evavold BD. TCR antagonism by peptide requires high TCR expression. Journal of Immunology (Baltimore, Md. : 1950). 181: 1760-6. PMID 18641313 DOI: 10.4049/Jimmunol.181.3.1760  0.789
2008 Wasserman HA, Evavold BD. Induction of anergy by antibody blockade of TCR in myelin oligodendrocyte glycoprotein-specific cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 7259-64. PMID 18490725 DOI: 10.4049/Jimmunol.180.11.7259  0.669
2008 Sabatino JJ, Shires J, Altman JD, Ford ML, Evavold BD. Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. Journal of Immunology (Baltimore, Md. : 1950). 180: 4451-7. PMID 18354166 DOI: 10.4049/Jimmunol.180.7.4451  0.844
2007 Huang J, Edwards LJ, Evavold BD, Zhu C. Kinetics of MHC-CD8 interaction at the T cell membrane. Journal of Immunology (Baltimore, Md. : 1950). 179: 7653-62. PMID 18025211 DOI: 10.4049/Jimmunol.179.11.7653  0.597
2006 Ford ML, Evavold BD. Modulation of MOG 37-50-specific CD8+ T cell activation and expansion by CD43. Cellular Immunology. 240: 53-61. PMID 16890924 DOI: 10.1016/J.Cellimm.2006.06.007  0.731
2005 Kumar S, Skeen MJ, Adiri Y, Yoon H, Vezys VD, Lukacher AE, Evavold BD, Ziegler HK, Boss JM. A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets. Cellular Immunology. 237: 131-40. PMID 16405934 DOI: 10.1016/J.Cellimm.2005.11.003  0.522
2005 Margot CD, Ford ML, Evavold BD. Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151. Journal of Immunology (Baltimore, Md. : 1950). 174: 3352-8. PMID 15749867 DOI: 10.4049/Jimmunol.174.6.3352  0.734
2005 Ford ML, Evavold BD. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. European Journal of Immunology. 35: 76-85. PMID 15593305 DOI: 10.1002/Eji.200425660  0.795
2004 Kilgore NE, Ford ML, Margot CD, Jones DS, Reichardt P, Evavold BD. Defining the parameters necessary for T-cell recognition of ligands that vary in potency. Immunologic Research. 29: 29-40. PMID 15181268 DOI: 10.1385/Ir:29:1-3:029  0.75
2004 Ryan KR, McNeil LK, Dao C, Jensen PE, Evavold BD. Modification of peptide interaction with MHC creates TCR partial agonists Cellular Immunology. 227: 70-78. PMID 15051516 DOI: 10.1016/J.Cellimm.2004.01.003  0.805
2004 Ford ML, Evavold BD. Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes. Molecular Immunology. 40: 1019-25. PMID 15036905 DOI: 10.1016/J.Molimm.2003.11.004  0.776
2004 Ford ML, Evavold BD. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis. European Journal of Immunology. 34: 388-97. PMID 14768043 DOI: 10.1002/Eji.200324502  0.709
2003 Ford ML, Onami TM, Sperling AI, Ahmed R, Evavold BD. CD43 modulates severity and onset of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 171: 6527-33. PMID 14662853 DOI: 10.4049/Jimmunol.171.12.6527  0.731
2003 Ford ML, Evavold BD. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55. Journal of Immunology (Baltimore, Md. : 1950). 171: 1247-54. PMID 12874212 DOI: 10.4049/Jimmunol.171.3.1247  0.762
2003 Kilgore NE, Carter JD, Lorenz U, Evavold BD. Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity. Journal of Immunology (Baltimore, Md. : 1950). 170: 4891-5. PMID 12734331 DOI: 10.4049/Jimmunol.170.10.4891  0.638
2003 McNeil LK, Evavold BD. TCR reserve: A novel principle of CD4 T cell activation by weak ligands Journal of Immunology. 170: 1224-1230. PMID 12538680 DOI: 10.4049/Jimmunol.170.3.1224  0.806
2002 McNeil LK, Evavold BD. Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation Proceedings of the National Academy of Sciences of the United States of America. 99: 4520-4525. PMID 11904393 DOI: 10.1073/Pnas.072673899  0.844
2000 Robertson JM, Jensen PE, Evavold BD. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. Journal of Immunology (Baltimore, Md. : 1950). 164: 4706-12. PMID 10779776 DOI: 10.4049/Jimmunol.164.9.4706  0.552
1998 Sourdive DJD, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C, Kourilsky P, Evavold B, Sette A, Ahmed R. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection Journal of Experimental Medicine. 188: 71-82. PMID 9653085 DOI: 10.1084/Jem.188.1.71  0.653
1998 Ryan KR, Evavold BD. Persistence of peptide-induced CD4+ T cell anergy in vitro. The Journal of Experimental Medicine. 187: 89-96. PMID 9419214 DOI: 10.1084/Jem.187.1.89  0.85
1996 Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA- DM Science. 274: 618-620. PMID 8849454 DOI: 10.1126/Science.274.5287.618  0.416
1995 Hsu BL, Evavold BD, Allen PM. Modulation of T cell development by an endogenous altered peptide ligand. The Journal of Experimental Medicine. 181: 805-10. PMID 7836933 DOI: 10.1084/Jem.181.2.805  0.665
1995 Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 2: 655-63. PMID 7540944 DOI: 10.1016/1074-7613(95)90010-1  0.559
1994 Evavold BD, Sloan-Lancaster J, Allen PM. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunology Today. 14: 602-9. PMID 8305133 DOI: 10.1016/0167-5699(93)90200-5  0.652
1994 Evavold BD, Sloan-Lancaster J, Allen PM. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proceedings of the National Academy of Sciences of the United States of America. 91: 2300-4. PMID 8134391 DOI: 10.1073/Pnas.91.6.2300  0.626
1994 Sloan-Lancaster J, Evavold BD, Allen PM. Th2 cell clonal anergy as a consequence of partial activation. The Journal of Experimental Medicine. 180: 1195-205. PMID 7931057 DOI: 10.1084/Jem.180.4.1195  0.604
1994 Hagerty DT, Evavold BD, Allen PM. Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4+ T cells. The Journal of Clinical Investigation. 93: 1208-15. PMID 7510717 DOI: 10.1172/Jci117074  0.595
1993 Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 363: 156-9. PMID 8483498 DOI: 10.1038/363156A0  0.648
1992 Ditzian-Kadanoff R, Parks L, Evavold B, Quintans J, Swartz TJ. Stimulation of peripheral blood T cells by an activated T-cell line: a novel human autologous T-T lymphocyte reaction. Scandinavian Journal of Immunology. 34: 713-9. PMID 1684247 DOI: 10.1111/J.1365-3083.1991.Tb01595.X  0.647
1992 Evavold BD, Allen PM. Dissection of the Hb(64-76) determinant reveals that the T cell receptor may have the capacity to differentially signal Advances in Experimental Medicine and Biology. 323: 17-22. PMID 1485563 DOI: 10.1007/978-1-4615-3396-2_3  0.521
1991 Evavold BD, Yokoyama A, Hirsch R, Bluestone JA, Quintans J. T helper 2 (Th2) but not Th1 clones co-stimulate resting T cells in the presence of anti-CD3 monoclonal antibody. International Immunology. 1: 443-9. PMID 2535137 DOI: 10.1093/Intimm/1.4.443  0.63
1991 Evavold BD, Allen PM. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (New York, N.Y.). 252: 1308-10. PMID 1833816 DOI: 10.1126/Science.1833816  0.657
1990 Tiegs SL, Evavold BD, Yokoyama A, Stec S, Quintans J, Rowley D. Delayed antigen presentation by epidermal Langerhans cells to cloned T h1 and T h2 cells. The Journal of Investigative Dermatology. 95: 446-9. PMID 2212728 DOI: 10.1111/1523-1747.Ep12555602  0.579
1988 Swartz TJ, Evavold B, Suzuki H, Yokoyama A, Quintans J. Antigenicity of passively acquired major histocompatibility antigens on T cells. Transplantation. 46: 137-43. PMID 3260698 DOI: 10.1097/00007890-198807000-00025  0.521
Show low-probability matches.